Opko Health Stock Current Asset
| OPK Stock | USD 1.58 0.02 1.28% |
Opko Health fundamentals help investors to digest information that contributes to Opko Health's financial success or failures. It also enables traders to predict the movement of Opko Stock. The fundamental analysis module provides a way to measure Opko Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Opko Health stock.
Non Current Assets Total is expected to rise to about 1.8 B this year, although the value of Total Current Assets will most likely fall to about 183.8 M. Opko | Current Asset |
Opko Health Company Current Asset Analysis
Opko Health's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Opko Health Current Asset | 454.06 M |
Most of Opko Health's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opko Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Opko Current Asset Historical Pattern
Today, most investors in Opko Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Opko Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Opko Health current asset as a starting point in their analysis.
Opko Health Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Opko Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Opko Health has a Current Asset of 454.06 M. This is 78.9% lower than that of the Biotechnology sector and 53.89% lower than that of the Health Care industry. The current asset for all United States stocks is 95.14% higher than that of the company.
Opko Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opko Health's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics of similar companies.Opko Health is currently under evaluation in current asset category among its peers.
Opko Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Opko Health from analyzing Opko Health's financial statements. These drivers represent accounts that assess Opko Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Opko Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 875.3M | 2.5B | 3.1B | 898.8M | 1.1B | 1.4B | |
| Enterprise Value | 1.0B | 2.7B | 3.2B | 959.1M | 1.4B | 1.5B |
Opko Fundamentals
| Return On Equity | -0.0939 | ||||
| Return On Asset | -0.0897 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.62) % | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 672.8 M | ||||
| Shares Owned By Insiders | 54.45 % | ||||
| Shares Owned By Institutions | 28.02 % | ||||
| Number Of Shares Shorted | 95.86 M | ||||
| Price To Earning | 7.46 X | ||||
| Price To Book | 0.76 X | ||||
| Price To Sales | 1.49 X | ||||
| Revenue | 863.5 M | ||||
| Gross Profit | 214.3 M | ||||
| EBITDA | (65.52 M) | ||||
| Net Income | (188.86 M) | ||||
| Cash And Equivalents | 210.46 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 326.56 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 2.06 X | ||||
| Cash Flow From Operations | (28.2 M) | ||||
| Short Ratio | 33.99 X | ||||
| Earnings Per Share | (0.19) X | ||||
| Price To Earnings To Growth | (2.87) X | ||||
| Target Price | 3.96 | ||||
| Number Of Employees | 3.93 K | ||||
| Beta | 1.65 | ||||
| Market Capitalization | 1.06 B | ||||
| Total Asset | 2.01 B | ||||
| Retained Earnings | (2.01 B) | ||||
| Working Capital | 109.42 M | ||||
| Current Asset | 454.06 M | ||||
| Current Liabilities | 251.9 M | ||||
| Net Asset | 2.01 B |
About Opko Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Opko Health Piotroski F Score and Opko Health Altman Z Score analysis. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share 0.998 | Quarterly Revenue Growth (0.03) | Return On Assets (0.09) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.